Coya Therapeutics announces common stock offering, no amount given

Coya Therapeutics (COYA) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The company intends to use the net proceeds from the proposed public offering for working capital and other general corporate purposes, including funding its clinical development plan. Lucid Capital Markets is acting as sole book-running manager for the proposed public offering.